Damora Therapeutics Statistics
NASDAQ: DMRAHealthcareBiotechnologyUSD
20.24+0.69 (+3.53%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Damora Therapeutics by the numbers
Damora Therapeutics has a market capitalization of $1.25 billion based on 61.74M shares outstanding. With trailing EPS of $-0.25, Damora Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.1% below its 50-day average and 22.3% below its 200-day average.
Average daily trading volume is 540.62K shares, or about $10.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DMRA valuation vs. peer median
| Metric | DMRA | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.25B | $1.31B | -4% |
| Avg. volume | 540.62K | 568.89K | -5% |
Peer median across 8 companies: NBTX, ORIC, REPL, KARD, DRTS, COAG, OMER, ANAB.
Valuation
- Market cap
- $1.25B
- EPS (TTM)
- $-0.25
- Shares outstanding
- 61.74M
Price and trading
- Previous close
- 19.55
- Open
- 19.36
- Day range
- 18.69 – 20.34
- 52-week range
- 4.95 – 38.33
- 52-week change
- +12.95%
- Beta
- —
- Volume
- 488.75K
- Average volume
- 540.62K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.25B
- Forward Pe
- -9.32
- Eps
- -0.25
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 38.33
- Week52 Low
- 4.95
- Avg Volume
- 540.62K
- Shares Outstanding
- 61.74M
- Ma50
- 27.02
- Ma200
- 26.04
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -47.19%
- Pct From52w Low
- 308.89%